Обзор рекомендаций Европейской антиревматической лиги (EULAR), рассмотренных в 2018 г.
https://doi.org/10.14412/1996-7012-2019-2-22-24
Аннотация
Об авторе
Т. В. БекетоваРоссия
115522 Москва, Каширское шоссе, 34А
Литература
1. Retamozo S. SP0159 EULAR recommendations for the management of Sjö gren's syndrome. Ann Rheum Dis. 2018 Jun;77 (Suppl 2):42.
2. Meijer JM, Meiners PM, Vissink A, et al. Effectiveness of Rituximab treatment in primary Sjö gren's syndrome. A Randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2010 Apr;62(4):960-8. doi: 10.1002/art.27314.
3. Bowman SJ, Everett CC, O'Dwyer JL, et al. Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjö gren's Syndrome. Arthritis Rheum. 2017 Jul;69(7):1440-1450. doi: 10.1002/art. 40093.
4. Hatemi G, Christensen R, Bang D, et al. 2018 update of the EULAR recommendations for the management of Behсet's syndrome. Ann Rheum Dis. 2018 Jun;77(6): 808-818. doi: 10.1136/annrheumdis-2018- 213225. Epub 2018 Apr 6.
5. Hatemi G, Silman A, Bang D, et al. EULAR recommendations for the management of Behсet disease. Ann Rheum Dis. 2008 Dec;67(12):1656-62. doi: 10.1136/ard.2007.080432. Epub 2008 Jan 31.
6. Elkayam O. SP0158 Update of eular recommendations for vaccination of patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2018 Jun;77 (Suppl 2):41.
7. Van Assen S, Agmon-Levin N, Elkayam O, et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2011 Mar;70(3):414-22. doi: 10.1136/ard.2010.137216. Epub 2010 Dec 3.
8. Hoes JN, Jacobs JW, Boers M, et al. EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis. 2007 Dec;66(12):1560-7. Epub 2007 Jul 27.
9. Van der Goes MC, Jacobs JW, Boers M, et al. Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis. 2010 Jun;69(6):1015-21. doi: 10.1136/ard.2009.114579.
10. Duru N, van der Goes MC, Jacobs JW, et al. EULAR evidence-based and consensusbased recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis. 2013 Dec;72(12):1905-13. doi: 10.1136/annrheumdis-2013-203249. Epub 2013 Jul 19.
11. Buttgereit F. SP0160 2018 EULAR recommendations for the use of glucocorticoid therapy. Ann Rheum Dis. 2018 Jun;77(Suppl 2):42.
12. Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007 Mar; 66(3):377-88. Epub 2006 Oct 17.
13. Kloppenburg M, Kroon FP, Blanco FJ, et al. 2018 update of the EULAR recommendations for the management of hand osteoarthritis. Ann Rheum Dis. 2019 Jan; 78(1):16-24. doi: 10.1136/annrheumdis2018-213826. Epub 2018 Aug 28.
14. Lems WF, Dreinhö fer KE, Bischoff-Ferrari H, et al. EULAR/EFORT recommendations for management of patients older than 50 years with a fragility fracture and prevention of subsequent fractures. Ann Rheum Dis. 2017 May;76(5): 802-810. doi: 10.1136/annrheumdis-2016- 210289. Epub 2016 Dec 22.
Рецензия
Для цитирования:
Бекетова ТВ. Обзор рекомендаций Европейской антиревматической лиги (EULAR), рассмотренных в 2018 г. Современная ревматология. 2019;13(2):22-24. https://doi.org/10.14412/1996-7012-2019-2-22-24
For citation:
Beketova TV. Review of the European League Against Rheumatism (EULAR) guidelines considered in 2018. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2019;13(2):22-24. (In Russ.) https://doi.org/10.14412/1996-7012-2019-2-22-24